Welcome to our dedicated page for DOCGO news (Ticker: DCGO), a resource for investors and traders seeking the latest updates and insights on DOCGO stock.
DocGo Inc. (NASDAQ: DCGO) is a provider of technology-enabled mobile health and medical transportation services, and its news flow reflects this focus on out‑of‑facility care. Company press releases highlight developments in its mobile health services, remote patient monitoring, ambulance and medical transport operations, and its 50‑state virtual care network.
Investors following DocGo news can expect regular updates on financial results, including quarterly earnings announcements furnished on Form 8‑K, where the company discusses segment performance for Mobile Health Services and Transportation Services, adjusted gross margin metrics and adjusted EBITDA. These releases often include commentary from management on contract activity, care gap closure volumes, and the evolution of its payer and provider relationships.
DocGo’s news also covers contract wins and program launches, such as care gap closure programs with insurance providers, population health initiatives with public health plans and tribal and state health departments, vaccination programs with counties, and multi‑year ambulance contracts with academic medical systems and municipalities. Announcements describing longitudinal care services and transitions of care programs illustrate how the company uses mobile clinicians and telehealth to engage patients at home.
Another recurring theme in DocGo news is strategic activity and capital allocation. The company has issued releases and filed 8‑Ks regarding the acquisition of virtual care platform SteadyMD, as well as updates on its share repurchase program. In addition, DocGo frequently announces participation in healthcare and growth investor conferences, providing insight into how management presents its strategy to the market.
For anyone tracking DCGO, this news page aggregates these earnings releases, contract announcements, program launches, acquisition updates and conference appearances in one place, offering a consolidated view of the company’s operational and strategic milestones over time.
DocGo (NASDAQ: DCGO) reported its Q4 and full-year 2024 financial results. Full-year revenue reached $616.6 million, slightly down from $624.2 million in 2023. The company's GAAP gross margin improved to 32.1% from 28.7% year-over-year, while net income increased to $13.4 million from $10.0 million.
Q4 2024 saw total revenue of $120.8 million, down from $199.2 million in Q4 2023, primarily due to migrant-related programs wind-down. The quarter resulted in a net loss of $7.6 million compared to $8.0 million net income in Q4 2023. The company surpassed 700,000 patient lives assigned for care gap closure programs.
For 2025 guidance, DocGo maintains revenue expectations of $410-450 million but revised adjusted EBITDA margin to approximately 5%, down from previous 8-10% estimate, due to increased investments in care gap closure programs and operational transition.
DocGo (Nasdaq: DCGO) announced its Ambulnz subsidiary has expanded its contract with a major Tennessee healthcare system to launch services in Chattanooga. The expansion focuses on providing advanced medical transportation services, including hospital discharges and transfers among skilled nursing, rehabilitation, and acute care facilities.
The Tennessee partnership currently supports approximately 17,000 annual trips, with projections to exceed 20,000 trips by 2025 and add 5,000 additional trips by 2026. The company has already demonstrated strong growth, increasing its Tennessee trip volume by over 25% in the past year. This expansion aims to improve healthcare coordination, reduce inefficiencies, enhance bed management, and optimize patient outcomes through seamless patient transport services.
DocGo (Nasdaq: DCGO), a leading provider of technology-enabled mobile health services, has announced its participation in the TD Cowen 45th Annual Health Care Conference. CEO Lee Bienstock will engage in one-on-one meetings and deliver a presentation on Wednesday, March 5th from 11:10 to 11:40 AM ET. The presentation will be accessible via webcast through DocGo's investor relations website section at ir.docgo.com.
DocGo (Nasdaq: DCGO), a leading provider of technology-enabled mobile health services, has scheduled its fourth quarter and full year 2024 financial results release for Thursday, February 27, 2025, after market close. The company will host a conference call and webcast at 5:00 p.m. ET on the same day to discuss the results.
Investors can access the conference call via U.S. toll-free number (1-800-717-1738) or international number (1-646-307-1865) using Conference ID 41220. A webcast will be available through the Investors section of DocGo's website.
DocGo (NASDAQ: DCGO) has acquired PTI Health, a mid-Atlantic mobile lab collection and phlebotomy services company, to expand its healthcare service offerings. The acquisition enhances DocGo's capabilities by incorporating PTI Health's existing partnerships with major labs and their ordering platform integrations.
The strategic move aims to address critical gaps in diagnostic care for underserved populations by providing mobile phlebotomy lab services and at-home testing. DocGo plans to initially expand PTI Health's operations into New York City. PTI Health's services focus on homebound patients and those facing transportation challenges, with their clinicians performing thousands of lab collections annually.
As part of the acquisition, PTI Health President Wayne Meadows will join DocGo as a General Manager. The company plans to leverage this acquisition to drive growth in 2025 and beyond, while expanding their mobile health offerings and strengthening their vertically integrated care model.
DocGo (Nasdaq: DCGO), a leading provider of technology-enabled mobile health services, has announced that CEO Lee Bienstock will participate in the Needham Annual Growth Conference. The participation includes a fireside chat scheduled for Wednesday, January 15th from 12:45 to 1:25 PM Eastern Time, along with one-on-one meetings during the event. Investors can access the webcast of the fireside chat through DocGo's investor relations website at ir.docgo.com.
DocGo (NASDAQ: DCGO) has expanded its partnership with SHL Telemedicine to integrate SmartHeart® portable 12-lead ECG devices across its mobile health care units nationwide, following initial deployment in the New York-New Jersey area. The collaboration aims to address the critical gap in cardiovascular care access, noting that 46% of U.S. counties lack cardiologists according to the Journal of the American College of Cardiology.
The partnership will enable high-quality ECG screenings in patients' homes and underserved communities, with cardiologist-reviewed results available promptly. The first phase of expansion will target California, focusing on rural communities and healthcare deserts. This initiative aims to improve patient outcomes while reducing emergency room visits and overall healthcare costs.
DocGo (Nasdaq: DCGO) announced that its Ambulnz subsidiary has renewed a two-year transportation contract with a major Tennessee healthcare system, extending their six-year partnership. The agreement covers hospital discharge transportation and interfacility transfers, currently handling approximately 17,000 trips annually with plans to exceed 20,000 trips per year. The company reported a 25% increase in trips over the past year, demonstrating growing demand. Through this partnership, DocGo aims to improve healthcare coordination, reduce inefficiencies, and enhance patient outcomes by ensuring seamless patient transport.
DocGo announced that its Cardiac RMS subsidiary has signed a contract with a major Mississippi hospital system to provide remote monitoring services for nearly 3,000 patients with cardiac implantable electronic devices (CIEDs). The service, scheduled to begin in early 2025, marks Cardiac RMS's entry into Mississippi and expands their pediatric customer base.
The initiative aims to address Mississippi's challenges, including high cardiovascular disease rates, specialized care access in rural areas, and healthcare provider shortages. The remote monitoring service will help reduce in-office visits, enable early interventions, enhance clinical efficiency, streamline operations, and reduce hospital readmissions.
Cardiac RMS will monitor various devices including pacemakers, implantable cardioverter-defibrillators, heart failure devices, and implantable loop recorders.
DocGo (Nasdaq: DCGO) has secured a two-year contract through its subsidiary EMS Direct to provide medical transportation services for a major health and hospital system in Fort Worth, North Texas. The agreement covers Basic Life Support, Advanced Life Support, and Critical Care transportation services. The contract was implemented in under 90 days, demonstrating DocGo's operational efficiency. This expansion strengthens DocGo's presence in Texas and positions the company for further growth in the Dallas area.
FAQ
What is the current stock price of DOCGO (DCGO)?
What is the market cap of DOCGO (DCGO)?
